Home / Infliximab / Belgium
BE ATC L04AB02 · updated 2 Nov 2026
Infliximab shortage in Belgium
Is there an Infliximab shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Infliximab product is reported short in Belgium, the first since 10 Aug 2026. The company estimate for the return is 31 Jan 2027. Main reason: other.
Also short in Austria. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Remsima 120 mg (Orifarm) inj. sol. s.c. pre-filled pen 6 x 1 ml | Celltrion Healthcare Hungary | 10 Aug 2026 | 31 Jan 2027 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.